Literature DB >> 8102630

Relationship between colony morphology and the life cycle of Haemophilus influenzae: the contribution of lipopolysaccharide phase variation to pathogenesis.

J N Weiser1.   

Abstract

Colonies of Haemophilus influenzae are heterogeneous in appearance because of phase variation in opacity. The only cell surface component found to have structural variation correlating with differences in opacity was the lipopolysaccharide (LPS). Changes in LPS structure, seen as migration patterns on tricine-SDS-PAGE, appeared to be independent of a previously described mechanism for generating LPS phase variation. The more transparent variants expressing a higher-molecular-weight LPS were serum sensitive and could efficiently colonize the infant rat nasopharynx after intranasal inoculation. In contrast, the fully opaque variant expressing a smaller-molecular-weight LPS was serum resistant, unable to colonize the nasopharynx, and more virulent when intraperitoneally administered. Organisms disseminating into the blood-stream from the nasopharynx changed phenotype from transparent to opaque. These findings demonstrate the potential importance of LPS structures that determine opacity in pathogenesis and colonization of mucosal surfaces.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8102630     DOI: 10.1093/infdis/168.3.672

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  22 in total

1.  Two-component systems in Haemophilus influenzae: a regulatory role for ArcA in serum resistance.

Authors:  J A De Souza-Hart; W Blackstock; V Di Modugno; I B Holland; M Kok
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

2.  Characterization of genetic and phenotypic diversity of invasive nontypeable Haemophilus influenzae.

Authors:  Alice L Erwin; Kevin L Nelson; Tendai Mhlanga-Mutangadura; Paul J Bonthuis; Jennifer L Geelhood; Gregory Morlin; William C T Unrath; Jose Campos; Derrick W Crook; Monica M Farley; Frederick W Henderson; Richard F Jacobs; Kathrin Mühlemann; Sarah W Satola; Loek van Alphen; Miriam Golomb; Arnold L Smith
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

3.  Haemophilus influenzae: then and now.

Authors:  J Z Jordens; M P Slack
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-11       Impact factor: 3.267

4.  Identification and characterization of a phase-variable nonfimbrial Salmonella typhimurium gene that alters O-antigen production.

Authors:  L Y Kwan; R E Isaacson
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

5.  Decoration of lipopolysaccharide with phosphorylcholine: a phase-variable characteristic of Haemophilus influenzae.

Authors:  J N Weiser; M Shchepetov; S T Chong
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

6.  Detection of the intercellular adhesion gene cluster (ica) and phase variation in Staphylococcus epidermidis blood culture strains and mucosal isolates.

Authors:  W Ziebuhr; C Heilmann; F Götz; P Meyer; K Wilms; E Straube; J Hacker
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

7.  Effect of amplification of the Cap b locus on complement-mediated bacteriolysis and opsonization of type b Haemophilus influenzae.

Authors:  G J Noel; A Brittingham; A A Granato; D M Mosser
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

Review 8.  Mechanisms of Bacterial Colonization of the Respiratory Tract.

Authors:  Steven J Siegel; Jeffrey N Weiser
Journal:  Annu Rev Microbiol       Date:  2015       Impact factor: 15.500

9.  Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization.

Authors:  J N Weiser; R Austrian; P K Sreenivasan; H R Masure
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

10.  Relationship between colonial morphology and adherence of Streptococcus pneumoniae.

Authors:  D R Cundell; J N Weiser; J Shen; A Young; E I Tuomanen
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.